UMHL yields 1000000.00% · JNJ yields 2.13%● Live data
📍 UMHL pulled ahead of the other in Year 1
Combined, UMHL + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UMHL + JNJ for your $10,000?
Umatrin Holding Limited, together with its subsidiaries, sells and trades in non-toxic beauty, personal care, health, and wellness products in Malaysia. Its products include Akero Afatelo, a nutrient product which contains telomerase and spirulina; Akero Karela that provides human body with the desired nutrient balance, activate cells, and strengthen the body organs; Unibersih for the treatment of constipation, pigmentation, overweight, bad breath, unsound sleep, lack of physical strength, indigestion, abdominal swelling, dry and pale skin, poor immune system, etc.; Sophielicous, an anti-aging supplement to enhance the longevity of skin cells; and AKERO SECRET, an anti-aging skin care series that include moisturizing cleansing foams, facial toners, brightening serums, soothing emulsions, and ageless and protective sunscreen creams. The company also offers Akero beauty serum to neutralize and repair the effects of emotional and environmental stress on the skin; Resveratrol, a natural antioxidant to reduce blood viscosity, inhibit platelet aggregation and vasodilation, maintain blood flow, and prevent the occurrence and development of various cardiovascular problems; Akero Gold Mask helps to renew skin and improve blood circulation, and is high in antioxidants and minerals; Akero Warming Lipstick; and Akero Feminine Wash, a specially designed sulfate-free intimate wash for a woman's special cleansing needs. It markets its products to retail-based end-users and dealers through an online platform; and a retail shop. The company is based in Kuala Lumpur, Malaysia.
Full UMHL Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.